bioAffinity Technologies (BIAF) Change in Account Payables (2021 - 2026)
bioAffinity Technologies (BIAF) posted quarterly Change in Account Payables of $74310.0 for Q1 2026, down 81.15% year-over-year from $394267.0 in Q1 2025, and up 141.55% quarter-over-quarter from -$178860.0 in Q4 2025.
bioAffinity Technologies (BIAF) Change in Account Payables (2021 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has reported Change in Account Payables for 6 consecutive years, with $74310.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Account Payables fell 81.15% year-over-year to $74310.0; the TTM figure through Mar 2026 stood at -$545367.0 (down 154.67% YoY), while the FY2025 annual figure was -$225410.0, down 158.93% from the prior year.
- Change in Account Payables rose to $74310.0 in Q1 2026 per BIAF's latest filing, from -$178860.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $577474.0 in Q3 2023 and bottomed at -$435285.0 in Q3 2022.
- Historically, Change in Account Payables has averaged $19503.2 across 5 years, with a median of $17284.0 in 2022.
- Annual changes were most pronounced in 2023 — Change in Account Payables plunged 1248.49% — and 2024, when it surged 1565.44%.
- bioAffinity Technologies' Change in Account Payables stood at $195360.0 in 2022, then sank by 315.67% to -$421337.0 in 2023, then surged by 148.51% to $204373.0 in 2024, then sank by 187.52% to -$178860.0 in 2025, then surged by 141.55% to $74310.0 in 2026.
- Business Quant data shows BIAF's Change in Account Payables at $74310.0 in Q1 2026, -$178860.0 in Q4 2025, and -$229076.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | - |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -38.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 13.74 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 15.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | - |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | -6.74 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 10.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 674,000.00 |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -11.70 Mn |
| 10 | bioAffinity Technologies | 1.78 Mn | -649,139.45 | - | 133,634.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 133,634.00 |
| Jun 30, 2026 | 133,634.00 |
| Mar 31, 2026 | 74,310.00 |
| Mar 31, 2026 | 74,310.00 |
| Dec 31, 2025 | -178,860.00 |
| Dec 31, 2025 | -178,860.00 |
| Sep 30, 2025 | -229,076.00 |
| Sep 30, 2025 | -229,076.00 |
| Jun 30, 2025 | -211,741.00 |
| Jun 30, 2025 | -211,741.00 |
| Mar 31, 2025 | 394,267.00 |
| Mar 31, 2025 | 394,267.00 |
| Dec 31, 2024 | 204,373.00 |
| Dec 31, 2024 | 204,373.00 |
| Sep 30, 2024 | -65,165.00 |
| Sep 30, 2024 | -65,165.00 |
| Jun 30, 2024 | 464,109.00 |
| Jun 30, 2024 | 464,109.00 |
| Mar 31, 2024 | -220,796.00 |
| Mar 31, 2024 | -220,796.00 |